These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30033030)

  • 21. Growth arrest-specific gene 6 is involved in glomerular hypertrophy in the early stage of diabetic nephropathy.
    Nagai K; Arai H; Yanagita M; Matsubara T; Kanamori H; Nakano T; Iehara N; Fukatsu A; Kita T; Doi T
    J Biol Chem; 2003 May; 278(20):18229-34. PubMed ID: 12644472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macrophages and dendritic cells use different Axl/Mertk/Tyro3 receptors in clearance of apoptotic cells.
    Seitz HM; Camenisch TD; Lemke G; Earp HS; Matsushima GK
    J Immunol; 2007 May; 178(9):5635-42. PubMed ID: 17442946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant Gas6 augments Axl and facilitates immune restoration in an intracerebral hemorrhage mouse model.
    Tong LS; Shao AW; Ou YB; Guo ZN; Manaenko A; Dixon BJ; Tang J; Lou M; Zhang JH
    J Cereb Blood Flow Metab; 2017 Jun; 37(6):1971-1981. PubMed ID: 27389179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mice lacking Axl and Mer tyrosine kinase receptors are susceptible to experimental autoimmune orchitis induction.
    Li N; Liu Z; Zhang Y; Chen Q; Liu P; Cheng CY; Lee WM; Chen Y; Han D
    Immunol Cell Biol; 2015 Mar; 93(3):311-20. PubMed ID: 25403570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feedback regulation of IFN-α/β signaling by Axl receptor tyrosine kinase modulates HBV immunity.
    Huang MT; Liu WL; Lu CW; Huang JJ; Chuang HL; Huang YT; Horng JH; Liu P; Han DS; Chiang BL; Shih C; Chen PJ; Chen DS
    Eur J Immunol; 2015 Jun; 45(6):1696-705. PubMed ID: 25820812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The TAM-family receptor Mer mediates production of HGF through the RhoA-dependent pathway in response to apoptotic cells.
    Park HJ; Baen JY; Lee YJ; Choi YH; Kang JL
    Mol Biol Cell; 2012 Aug; 23(16):3254-65. PubMed ID: 22740630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rag1-null Dahl SS rats reveal that adaptive immune mechanisms exacerbate high protein-induced hypertension and renal injury.
    Abais-Battad JM; Lund H; Fehrenbach DJ; Dasinger JH; Mattson DL
    Am J Physiol Regul Integr Comp Physiol; 2018 Jul; 315(1):R28-R35. PubMed ID: 29537860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cilostazol inhibits uremic toxin-induced vascular smooth muscle cell dysfunction: role of Axl signaling.
    Lee CH; Hung YJ; Shieh YS; Chien CY; Hsu YJ; Lin CY; Chiang CF; Huang CL; Hsieh CH
    Am J Physiol Renal Physiol; 2017 Mar; 312(3):F398-F406. PubMed ID: 27927649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Axl and Mer Receptor Tyrosine Kinases: Distinct and Nonoverlapping Roles in Inflammation and Cancer?
    Dransfield I; Farnworth S
    Adv Exp Med Biol; 2016; 930():113-32. PubMed ID: 27558819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sertoli cell-initiated testicular innate immune response through toll-like receptor-3 activation is negatively regulated by Tyro3, Axl, and mer receptors.
    Sun B; Qi N; Shang T; Wu H; Deng T; Han D
    Endocrinology; 2010 Jun; 151(6):2886-97. PubMed ID: 20363878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of the Axl receptor tyrosine kinase induces mitogenesis and transformation in 32D cells.
    McCloskey P; Pierce J; Koski RA; Varnum B; Liu ET
    Cell Growth Differ; 1994 Oct; 5(10):1105-17. PubMed ID: 7848912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Axl-dependent signalling: a clinical update.
    Korshunov VA
    Clin Sci (Lond); 2012 Apr; 122(8):361-8. PubMed ID: 22187964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The receptor tyrosine kinase Axl in cancer: biological functions and therapeutic implications.
    Paccez JD; Vogelsang M; Parker MI; Zerbini LF
    Int J Cancer; 2014 Mar; 134(5):1024-33. PubMed ID: 23649974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TAM receptor tyrosine kinases as emerging targets of innate immune checkpoint blockade for cancer therapy.
    Akalu YT; Rothlin CV; Ghosh S
    Immunol Rev; 2017 Mar; 276(1):165-177. PubMed ID: 28258690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of Gas6 and Axl signaling results in extensive axonal damage, motor deficits, prolonged neuroinflammation, and less remyelination following cuprizone exposure.
    Ray AK; DuBois JC; Gruber RC; Guzik HM; Gulinello ME; Perumal G; Raine C; Kozakiewicz L; Williamson J; Shafit-Zagardo B
    Glia; 2017 Dec; 65(12):2051-2069. PubMed ID: 28925029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Receptor tyrosine kinase AXL is induced by chemotherapy drugs and overexpression of AXL confers drug resistance in acute myeloid leukemia.
    Hong CC; Lay JD; Huang JS; Cheng AL; Tang JL; Lin MT; Lai GM; Chuang SE
    Cancer Lett; 2008 Sep; 268(2):314-24. PubMed ID: 18502572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testosterone delays vascular smooth muscle cell senescence and inhibits collagen synthesis via the Gas6/Axl signaling pathway.
    Chen YQ; Zhao J; Jin CW; Li YH; Tang MX; Wang ZH; Zhang W; Zhang Y; Li L; Zhong M
    Age (Dordr); 2016 Jun; 38(3):60. PubMed ID: 27206970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Axl mediates tumor invasion and chemosensitivity through PI3K/Akt signaling pathway and is transcriptionally regulated by slug in breast carcinoma.
    Li Y; Jia L; Ren D; Liu C; Gong Y; Wang N; Zhang X; Zhao Y
    IUBMB Life; 2014 Jul; 66(7):507-18. PubMed ID: 24984960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Receptor tyrosine kinase Axl is required for resistance of leukemic cells to FLT3-targeted therapy in acute myeloid leukemia.
    Park IK; Mundy-Bosse B; Whitman SP; Zhang X; Warner SL; Bearss DJ; Blum W; Marcucci G; Caligiuri MA
    Leukemia; 2015 Dec; 29(12):2382-9. PubMed ID: 26172401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immuno-oncological Efficacy of RXDX-106, a Novel TAM (TYRO3, AXL, MER) Family Small-Molecule Kinase Inhibitor.
    Yokoyama Y; Lew ED; Seelige R; Tindall EA; Walsh C; Fagan PC; Lee JY; Nevarez R; Oh J; Tucker KD; Chen M; Diliberto A; Vaaler H; Smith KM; Albert A; Li G; Bui JD
    Cancer Res; 2019 Apr; 79(8):1996-2008. PubMed ID: 30723115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.